High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis
Abstract Background Pancreatic adenocarcinoma (PAAD) is one of the most challenging cancers with high morbidity and mortality. KRAS mutations could occur as an early event in PAAD. The present study aimed to identify the differentially expressed lncRNAs (DE-lncRNAs) and differentially expressed mRNA...
Saved in:
Main Authors: | Chengming Tian (Author), Xiyao Li (Author), Chunlin Ge (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THZ1: Towards KRAS mutation‐based precision medicine against pancreatic ductal adenocarcinoma
by: Yansong Qin, et al.
Published: (2024) -
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
by: Pinaki Mondal, et al.
Published: (2023) -
Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis
by: Shuai Tang, et al.
Published: (2023) -
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
by: Lili Wang, et al.
Published: (2017) -
Molecular analysis of TCGA breast cancer histologic types
by: Aatish Thennavan, et al.
Published: (2021)